Literature DB >> 4252830

The incorporation of 51Cr-3, 4-dihydroxyphenylalanine (DOPA) complex into melanoma B 16.

L J Anghileri, E S Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4252830     DOI: 10.1007/bf00524745

Source DB:  PubMed          Journal:  Z Krebsforsch        ISSN: 0301-1585


× No keyword cloud information.
  16 in total

1.  [Autoradiographic studies on protein and melanin metabolism in different cell types in melanoma in mice (Harding-Passey type)].

Authors:  K HEMPEL; W ERB
Journal:  Z Zellforsch Mikrosk Anat       Date:  1962

2.  Homovanillic acid and its relation to tyrosine metabolism in melanoma.

Authors:  J DUCHON; V GREGORA
Journal:  Clin Chim Acta       Date:  1962-05       Impact factor: 3.786

3.  Precursors of adrenal epinephrine and norepinephrine in vivo.

Authors:  S UDENFRIEND; J B WYNGAARDEN
Journal:  Biochim Biophys Acta       Date:  1956-04

4.  The chemistry of melanin; mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase.

Authors:  H S MASON
Journal:  J Biol Chem       Date:  1948-01       Impact factor: 5.157

5.  Radioactivity from labeled precursors of melanin in mice and hamsters with melanomas.

Authors:  D A Meier; W H Beierwaltes; R E Counsell
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

6.  Biochemical approach to a tumor localizing agent: 51Cr-beta-glycerophosphate complex.

Authors:  L J Anghileri
Journal:  Oncology       Date:  1970       Impact factor: 2.935

7.  Cation exchange properties of bone tissue.

Authors:  L J Anghileri
Journal:  Experientia       Date:  1969-03-15

8.  Distribution and metabolism of DL-3,4-dihydroxy[2-14C]-phenylalanine in rat tissues.

Authors:  K F Gey; A Pletscher
Journal:  Biochem J       Date:  1964-08       Impact factor: 3.857

9.  Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

Authors:  A Pletscher; G Bartholini; R Tissot
Journal:  Brain Res       Date:  1967-02       Impact factor: 3.252

10.  [On the possibility of using 3-(3,4-dihydroxyphenyl)-alanine (DOPA) as a mediator of radioisotopes in a melanoma].

Authors:  V M Vdovenko; I I Ivanov; V N Bobrova; I S Gavrilenko; A I Ivanov; A L Solov'ev; L N Rumiantseva
Journal:  Dokl Akad Nauk SSSR       Date:  1965-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.